- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The Wall Street Journal reported that Zoetis Inc., a former subsidiary of Pfizer Inc. (NYSE:PFE), raised approximately $2.2 billion in its initial public offering (IPO) — that makes it the largest IPO since Facebook Inc.’s (NASDAQ:FB) in May 2012.
The Wall Street Journal reported that Zoetis Inc., a former subsidiary of Pfizer Inc. (NYSE:PFE), raised approximately $2.2 billion in its initial public offering (IPO) — that makes it the largest IPO since Facebook Inc.’s (NASDAQ:FB) in May 2012.
As quoted in the market news:
The $26 price was more than the range of $22 to $25 initially outlined in documents filed with the Securities and Exchange Commission. Zoetis will command a market value of around $13 billion based on the offer price.
Zoetis, of Madison, N.J., is the largest animal-medicine company in the world by revenue. It makes vaccines and drugs for livestock such as cattle and swine, as well as for pets.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.